| scholarly article | Q13442814 |
| P356 | DOI | 10.1074/JBC.M207160200 |
| P698 | PubMed publication ID | 12228247 |
| P50 | author | Tilman Sanchez-Elsner | Q37377391 |
| Carmelo Bernabeu | Q40038364 | ||
| P2093 | author name string | Luisa M Botella | |
| Carmen Langa | |||
| Beatriz Velasco | |||
| P2860 | cites work | HMEC-1: establishment of an immortalized human microvascular endothelial cell line | Q41592068 |
| P433 | issue | 46 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hypoxia | Q105688 |
| cooperation | Q380962 | ||
| P304 | page(s) | 43799-43808 | |
| P577 | publication date | 2002-09-11 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Endoglin expression is regulated by transcriptional cooperation between the hypoxia and transforming growth factor-beta pathways | |
| P478 | volume | 277 |
| Q41840622 | A novel CD105 determination system based on an ultrasensitive bioelectrochemical strategy with Pt nanoparticles |
| Q36205086 | A phase I first-in-human study of TRC105 (Anti-Endoglin Antibody) in patients with advanced cancer |
| Q92183830 | A solution to prevent secondary flow in adherent cell cultures |
| Q34558522 | Alteration in endoglin-related angiogenesis in refractory cytopenia with multilineage dysplasia |
| Q37298556 | An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. |
| Q36061812 | An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer |
| Q24803467 | Angiogenesis in male breast cancer |
| Q37835102 | Angiogenesis in meningiomas |
| Q54415099 | Angiogenesis-related gene expression profiling in ventilated preterm human lungs. |
| Q33748650 | Angiotensin receptor agonistic autoantibody-mediated tumor necrosis factor-alpha induction contributes to increased soluble endoglin production in preeclampsia |
| Q52714924 | Antagonizing CD105 enhances radiation sensitivity in prostate cancer. |
| Q26775947 | Anti-angiogenic alternatives to VEGF blockade |
| Q36964141 | Autologous preconditioned mesenchymal stem cell sheets improve left ventricular function in a rabbit old myocardial infarction model |
| Q34454218 | BMP and TGFbeta pathways in human central chondrosarcoma: enhanced endoglin and Smad 1 signaling in high grade tumors |
| Q36410172 | BMP9 regulates endoglin-dependent chemokine responses in endothelial cells |
| Q64069591 | Bioreactor-Controlled Physoxia Regulates TGF-β Signaling to Alter Extracellular Matrix Synthesis by Human Chondrocytes |
| Q34873983 | CD24 expression identifies teratogen-sensitive fetal neural stem cell subpopulations: evidence from developmental ethanol exposure and orthotopic cell transfer models. |
| Q41831569 | Cardiosphere-derived cell sheet primed with hypoxia improves left ventricular function of chronically infarcted heart |
| Q36978952 | Cellular oxygen sensing in health and disease |
| Q51734986 | Characterization of immortalized human dermal microvascular endothelial cells (HMEC-1) for the study of HDL functionality. |
| Q33619784 | Characterization of the human Activin-A receptor type II-like kinase 1 (ACVRL1) promoter and its regulation by Sp1 |
| Q51118037 | Chronic telogen effluvium and female pattern hair loss are separate and distinct forms of alopecia: a histomorphometric and immunohistochemical analysis. |
| Q36772545 | Circulating and placental endoglin concentrations in pregnancies complicated by intrauterine growth restriction and preeclampsia |
| Q43600447 | Clinical significance of soluble-endoglin levels in systemic lupus erythematosus: possible association with anti-phospholipid syndrome |
| Q38008197 | Compensation: a contemporary regulatory machinery in cardiovascular diseases? |
| Q53420337 | Contrast-enhanced molecular ultrasound differentiates endoglin genotypes in mouse embryos. |
| Q26995380 | Contrasting roles of different endoglin forms in atherosclerosis |
| Q35051350 | Copy number variations in endoglin locus: mapping of large deletions in Spanish families with hereditary hemorrhagic telangiectasia type 1. |
| Q33241639 | Correlation between CD105 expression and postoperative recurrence and metastasis of hepatocellular carcinoma |
| Q91465312 | DLC-1 tumor suppressor regulates CD105 expression on human non-small cell lung carcinoma cells through inhibiting TGF-β1 signaling |
| Q47283890 | Differential effects of TGF-beta1 and BMP-4 on the hypoxic induction of cyclooxygenase-2 in human pulmonary artery smooth muscle cells |
| Q40547600 | Differential regulation of VEGF by TGF-beta and hypoxia in rat proximal tubular cells. |
| Q42012692 | Effects of Hypoxia on the Immunomodulatory Properties of Adipose Tissue-Derived Mesenchymal Stem cells |
| Q33392329 | Effects of hypoxia-inducible factor-1alpha overexpression in pregnant mice: possible implications for preeclampsia and intrauterine growth restriction |
| Q24314256 | Endoglin (CD105) as a urinary and serum marker of prostate cancer |
| Q58352287 | Endoglin (CD105) expression in human renal cell carcinoma |
| Q36756322 | Endoglin (CD105) up-regulation in pulmonary microvasculature of ventilated preterm infants |
| Q28207513 | Endoglin (CD105): a powerful therapeutic target on tumor-associated angiogenetic blood vessels |
| Q43121223 | Endoglin - a marker of vascular endothelial cell proliferation in cancer |
| Q47968783 | Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia |
| Q84718191 | Endoglin as a marker in cervical paragangliomas |
| Q38180309 | Endoglin for targeted cancer treatment |
| Q38074721 | Endoglin for tumor imaging and targeted cancer therapy. |
| Q33728841 | Endoglin in liver fibrogenesis: Bridging basic science and clinical practice |
| Q37804900 | Endoglin-Targeted Cancer Therapy |
| Q89719911 | Endoglin: Beyond the Endothelium |
| Q36825271 | Endoglin: a critical mediator of cardiovascular health |
| Q37163424 | Endothelial dysfunction and hypertension in obstructive sleep apnea - Is it due to intermittent hypoxia? |
| Q36980048 | Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response. |
| Q54577295 | Exercise induces interleukin-8 receptor (CXCR2) expression in human skeletal muscle. |
| Q36620289 | Expression and localization of COMMD1 proteins in human placentas from women with preeclampsia |
| Q33454185 | Expression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women. |
| Q52935484 | Expression of hypoxia-inducible transcription factors in developing human and rat kidneys. |
| Q35158941 | Facilitation of endoglin-targeting cancer therapy by development/utilization of a novel genetically engineered mouse model expressing humanized endoglin (CD105) |
| Q27310820 | Four jointed box 1 promotes angiogenesis and is associated with poor patient survival in colorectal carcinoma |
| Q89846141 | HIF-hypoxia signaling in skeletal muscle physiology and fibrosis |
| Q38631740 | Hepatitis C Virus Core Protein Modulates Endoglin (CD105) Signaling Pathway for Liver Pathogenesis |
| Q24798737 | Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer |
| Q41874517 | Housekeeping genes tend to show reduced upstream sequence conservation. |
| Q42936902 | Human Mesenchymal Stem Cells Display Reduced Expression of CD105 after Culture in Serum-Free Medium. |
| Q28573546 | Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression |
| Q34062916 | Hypoxia inhibition of adipocytogenesis in human bone marrow stromal cells requires transforming growth factor-beta/Smad3 signaling |
| Q28202069 | Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene |
| Q39768636 | Hypoxia-activated Smad3-specific dephosphorylation by PP2A. |
| Q27023291 | Hypoxia-inducible factor 1 and cardiovascular disease |
| Q36012603 | Hypoxia-inducible factor signaling in the development of kidney fibrosis |
| Q37140405 | Hypoxia-inducible factor signaling in the development of tissue fibrosis |
| Q49311596 | Hypoxia-inducible factor-1α activates transforming growth factor-β1/Smad signaling and increases collagen deposition in dermal fibroblasts |
| Q41652349 | Hypoxia-inducible factor-1α promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3. |
| Q28303287 | Hypoxia-inducible factors in the kidney |
| Q26768865 | Hypoxia: The Force that Drives Chronic Kidney Disease |
| Q28575076 | Identification of endoglin in rat hepatic stellate cells: new insights into transforming growth factor beta receptor signaling |
| Q35741707 | Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma |
| Q35458472 | Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction |
| Q36048062 | Impairment of Angiogenic Sphingosine Kinase-1/Sphingosine-1-Phosphate Receptors Pathway in Preeclampsia. |
| Q30826592 | Infantile Hemangioma Originates From A Dysregulated But Not Fully Transformed Multipotent Stem Cell. |
| Q46005037 | Influence of hypoxia on the stemness of umbilical cord matrix-derived mesenchymal stem cells cultured on chitosan films. |
| Q24294521 | Interaction and functional interplay between endoglin and ALK-1, two components of the endothelial transforming growth factor-beta receptor complex |
| Q34784162 | Interdependence of HIF-1α and TGF-β/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression |
| Q92689429 | Krüppel-like factor 6 mediates pulmonary angiogenesis in rat experimental hepatopulmonary syndrome and is aggravated by bone morphogenetic protein 9 |
| Q34778717 | Landscape of transcriptional deregulations in the preeclamptic placenta |
| Q33802290 | Leucine-rich alpha 2 glycoprotein promotes Th17 differentiation and collagen-induced arthritis in mice through enhancement of TGF-β-Smad2 signaling in naïve helper T cells. |
| Q30431758 | Mechanistic exploration of phthalimide neovascular factor 1 using network analysis tools |
| Q36085112 | Modulation of endoglin expression in islets of langerhans by VEGF reveals a novel regulator of islet endothelial cell function |
| Q43023440 | Molecular pathways of early CD105-positive erythroid cells as compared with CD34-positive common precursor cells by flow cytometric cell-sorting and gene expression profiling |
| Q36375250 | Morphological study and comprehensive cellular constituents of milky spots in the human omentum |
| Q36246414 | Neurovascular phenotypes in hereditary haemorrhagic telangiectasia patients according to age. Review of 50 consecutive patients aged 1 day-60 years |
| Q50457112 | Oscillating glucose and constant high glucose induce endoglin expression in endothelial cells: the role of oxidative stress. |
| Q37788021 | Oxygen homeostasis |
| Q26827518 | Oxygen sensing in retinal health and disease |
| Q36842794 | Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. |
| Q39062393 | PRH/HHex inhibits the migration of breast and prostate epithelial cells through direct transcriptional regulation of Endoglin. |
| Q33289829 | Particular distribution and expression pattern of endoglin (CD105) in the liver of patients with hepatocellular carcinoma |
| Q35928851 | Pathophysiological Consequences of HIF Activation: HIF as a modulator of fibrosis |
| Q48337810 | Placental oxidative stress and maternal endothelial function in pregnant women with normotensive fetal growth restriction. |
| Q33849478 | Polymorphisms in the hypoxia-inducible factor 1 alpha gene in Mexican patients with preeclampsia: A case-control study |
| Q38207099 | Predictive biomarkers of pre-eclampsia and effectiveness of preventative interventions for the disease |
| Q35607362 | Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth |
| Q36485190 | Regulation of angiogenesis by hypoxia-inducible factor 1. |
| Q60915777 | Role of Endoglin (CD105) in the Progression of Hepatocellular Carcinoma and Anti-Angiogenic Therapy |
| Q42138913 | Role of Radiation-induced TGF-beta Signaling in Cancer Therapy |
| Q48425540 | Role of endoglin and transforming growth factor-beta in progressive white matter damage after an ischemic stroke. |
| Q36677493 | Role of transforming growth factor-beta in cancer progression |
| Q24304467 | Severe intrauterine growth restriction pregnancies have increased placental endoglin levels: hypoxic regulation via transforming growth factor-beta 3 |
| Q34324856 | Sp1-dependent regulation of the RTP801 promoter and its application to hypoxia-inducible VEGF plasmid for ischemic disease |
| Q28568288 | TGF-beta repression of Id2 induces apoptosis in gut epithelial cells |
| Q37959017 | TGF-β and its coreceptors in cancerogenesis: an overview |
| Q35354812 | TGFβ-induced deptor suppression recruits mTORC1 and not mTORC2 to enhance collagen I (α2) gene expression |
| Q35628653 | Targeting tumor vasculature with novel Listeria-based vaccines directed against CD105. |
| Q36419224 | The VHL/HIF oxygen-sensing pathway and its relevance to kidney disease |
| Q37775427 | The physiological role of endoglin in the cardiovascular system. |
| Q38273688 | The role of endoglin in kidney fibrosis |
| Q39036151 | The role of endoglin in post-ischemic revascularization. |
| Q46528698 | The roles of endoglin gene in cerebrovascular diseases |
| Q26796634 | Tipping the balance from angiogenesis to fibrosis in CKD |
| Q37161440 | Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show? |
| Q37967810 | Transforming Growth Factor-β and Endoglin Signaling Orchestrate Wound Healing |
| Q34811268 | Tumor angiogenesis change estimated by using diffuse optical spectroscopic tomography: demonstrated correlation in women undergoing neoadjuvant chemotherapy for invasive breast cancer? |
| Q83698012 | Tumor angiogenesis: role in locally aggressive biological behavior of ameloblastoma and keratocystic odontogenic tumor |
| Q33526842 | Tungsten carbide cobalt nanoparticles exert hypoxia-like effects on the gene expression level in human keratinocytes |
| Q36362933 | Upstream stimulatory factor 2 and hypoxia-inducible factor 2α (HIF2α) cooperatively activate HIF2 target genes during hypoxia |
| Q79293860 | Use of hypoxia‐inducible factor signal transduction pathway to measure O2 levels and modulate growth factor pathways |
| Q46339760 | Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. |
| Q37154944 | VHL Type 2B gene mutation moderates HIF dosage in vitro and in vivo |
| Q30492901 | Vascular endothelial growth factor receptor signaling is required for cardiac valve formation in zebrafish. |
| Q86029497 | Vasotrophic regulation of age-dependent hypoxic cerebrovascular remodeling |
| Q37002991 | Xtalk: a path-based approach for identifying crosstalk between signaling pathways |
| Q47070478 | scylla and charybde, homologues of the human apoptotic gene RTP801, are required for head involution in Drosophila |
Search more.